Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eton Pharmaceuticals, Inc.

16.97
-0.3700-2.13%
Post-market: 16.970.00000.00%16:05 EDT
Volume:253.33K
Turnover:4.31M
Market Cap:455.09M
PE:-114.95
High:17.34
Open:17.29
Low:16.73
Close:17.34
Loading ...

Eton Pharmaceuticals Inc expected to post earnings of 2 cents a share - Earnings Preview

Reuters
·
02 May

Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025

GlobeNewswire
·
02 May

Eton Pharmaceuticals, Inc. (ETON) Earnings Expected to Grow: What to Know Ahead of Q1 Release

Zacks
·
01 May

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Harmony Biosciences Holdings (HRMY), Apellis Pharmaceuticals (APLS) and Eton Pharmaceuticals (ETON)

TIPRANKS
·
28 Apr

Eton Pharmaceuticals Submits NDA to FDA for ET-600 to Treat Central Diabetes Insipidus

MT Newswires Live
·
28 Apr

BRIEF-Eton Pharmaceuticals Says FDA Review Expected To Take 10 Months, Potential Q1 2026 Launch

Reuters
·
28 Apr

Eton Pharmaceuticals Announces Submission of Nda for Et-600 (Desmopressin Oral Solution)

THOMSON REUTERS
·
28 Apr

Eton Pharmaceuticals Inc - FDA Review Expected to Take 10 Months, Potential Q1 2026 Launch

THOMSON REUTERS
·
28 Apr

Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution)

GlobeNewswire
·
28 Apr

B.Riley Financial Remains a Buy on Eton Pharmaceuticals (ETON)

TIPRANKS
·
17 Apr

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Has Found A Path To Profitability

Simply Wall St.
·
15 Apr

BUZZ-Eton Pharma falls after co licenses rare disease drug to Spanish company

Reuters
·
01 Apr

Craig-Hallum Sticks to Their Buy Rating for Eton Pharmaceuticals (ETON)

TIPRANKS
·
01 Apr

Eton Pharmaceuticals Agrees to License International Rights for Increlex to Esteve Pharmaceuticals

MT Newswires Live
·
01 Apr

BRIEF-Eton Pharmaceuticals Inc - Esteve To Pay Eur4 Million Up Front For Increlex Rights - SEC Filing

Reuters
·
01 Apr

Eton Pharmaceuticals Inc - Esteve Has Option to Acquire International Rights to Increlex for EUR6 Million - SEC Filing

THOMSON REUTERS
·
01 Apr

BRIEF-ESTEVE Signs License & Supply Agreement With Eton Pharmaceuticals With Global Rights For Increlex, Except For USA

Reuters
·
01 Apr

Esteve: Signs License & Supply Agreement With Eton Pharmaceuticals With Global Rights for Increlex, Except for USA

THOMSON REUTERS
·
01 Apr

Eton Pharmaceuticals Out-Licenses International Rights to Increlex®

GlobeNewswire
·
01 Apr

Eton Pharmaceuticals Is Maintained at Buy by Craig-Hallum

Dow Jones
·
20 Mar